Joined: 05 Jul 2018
|Posted: Wed 8 Aug - 02:35 (2018) Post subject: The disease progresses
|Gabon won a three-country contest against Algeria and Ghana on Wednesday to host the 2017 Africa Cup of Nations soccer tournament.
The result of a vote among 14 Confederation of African Football (CAF) executive committee members was announced mid-afternoon in a Cairo hotel after the three candidates made short presentations.
The Gabonese were co-hosts with neighbors Equatorial Guinea of the 2012 Cup of -Nations.
A Gabonese Football Federation official said matches would be staged in capital city Libreville Adidas NMD R1 x Gucci Mesh Schwarz Schweiz , Franceville, Port Gentil and Oyem.
Stadiums in Libreville and Franceville were used for the 2012 tournament and the other two venues are expected to be ready by mid-2016.
They will be the second successive central African country to host the championship after Equatorial Guinea this year.
Choosing Gabon ended a 1,529-day saga over who would host the next edition of the -biennial African showpiece.
South Africa was selected as 2017 host four years ago, but traded tournaments with 2013 hosts Libya because of post-Muammar Gaddafi-era violence in the north African state.
As deadly Libyan inter--militia fighting intensified, the oil-rich country was forced to withdraw as 2017 host as well.
Algeria, Egypt Herren Adidas NMD R1 W Cargo Grün Schweiz , Gabon, Ghana, Kenya, Sudan and Zimbabwe then applied to stage the three-week tournament.
But CAF dropped Kenya, Sudan and Zimbabwe from the bidding contest, saying they did not meet the criteria to host the tournament.
Kenya (1996) and Zimbabwe (2000) had previously been selected as Cup of Nations hosts only to pull out due to lack of finance.
Egypt later withdrew didas NMD R2 PK PrimeKnit Weiß Rot Schweiz , saying they did not wish to compete against fellow Arab nation -Algeria.
Before the selection of -Gabon, north and west African countries staged 10 tournaments each, east Africa five, central Africa four and -southern Africa three.
There were two co-hostings - Ghana and Nigeria in 2000, as late replacements for Zimbabwe, and Equatorial Guinea and Gabon three years ago.
CAF have already desig-nated the hosts of the 2019 (Cameroon) Herren Pharrell x Adidas NMD Human Race Rot Schwarz Schweiz , 2021 (Cote d'Ivoire) and 2023 finals (Guinea).
WASHINGTON, Aug. 30 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Wednesday approved the country's first gene therapy that reengineers people's own immune cells to treat childhood leukemia.
In a statement, the FDA called the approval "a historic action," saying it will usher in "a new approach to the treatment of cancer and other serious and life-threatening diseases."
"We're entering a new frontier in medical innovation with the ability to reprogram a patient's own cells to attack a deadly cancer," said FDA Commissioner Scott Gottlieb.
"New technologies such as gene and cell therapies hold out the potential to transform medicine and create an inflection point in our ability to treat and even cure many intractable illnesses."
The U.S. regulator approved Novartis's Kymriah (tisagenlecleucel), formerly known as CTL019 Herren Pharrell x Adidas NMD Human Race Grau Schwarz Schweiz , for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.
Kymriah is a novel immunotherapy using an individual patient's own T-cells, a type of white blood cell known as a lymphocyte.
The patient's T-cells are collected and sent to a manufacturing center where they are genetically modified to include a new gene that contains a specific protein, known as a chimeric antigen receptor or CAR, that directs the T-cells to target and kill leukemia cells that have a specific antigen, CD19, on the surface.
Once the cells are modified Herren Pharrell x Adidas NMD Human Race Grün Schwarz Schweiz , they are infused back into the patient to kill the cancer cells.
"Kymriah is a first-of-its-kind treatment approach that fills an important unmet need for children and young adults with this serious disease," said Peter Marks, director of the FDA's Center for Biologics Evaluation and Research.
"Not only does Kymriah provide these patients with a new treatment option where very limited options existed, but a treatment option that has shown promising remission and survival rates in clinical trials."
The safety and efficacy of Kymriah were demonstrated in one multicenter clinical trial of 63 pediatric and young adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia. The overall remission rate within three months of treatment was 83 percent.
Acute lymphoblastic leukemia is a cancer of the bone marrow and blood, in which the body makes abnormal lymphocytes.
The disease progresses quickly and is the most common childhood cancer in the U.S., with about 3 Pharrell x adidas NMD Human Race Schwarz Gelb Schweiz ,100 patients aged 20 and younger being diagnosed each year.
Patients often undergo multiple treatments including chemotherapy, radiation, targeted therapy or stem cell transplant, yet less than 10 percent of patients survive five years.
Acute lymphoblastic leukemia can be of either T- or B-cell origin, with B-cell the most common.
Kymriah is approved for use in pediatric and young adult patients with B-cell acute lymphoblastic leukemia and is intended for patients whose cancer has not responded to or has returned after initial treatment, which occurs in an estimated 15-20 percent of patients.
"Five years ago Pharrell x adidas NMD Human Race Orange Schwarz Schweiz , we began collaborating with the University of Pennsylvania (Penn) and invested in further developing and bringing what we believed would be a paradigm-changing immunocellular therapy to cancer patients in dire need," Joseph Jimenez, CEO of Novartis, said in a statement.
"With the approval of Kymriah, we are once again delivering on our commitment to change the course of cancer care," said Jimenez.
Carl June Herren Pharrell x adidas NMD Human Race Schwarz Weiß Schweiz , director of the Center for Cellular Immunotherapies in Penn's Perelman School of Medicine, who is a pioneer of this new treatment, called the approval "a significant step forward in individualized cancer treatment that may have a. Wholesale Jerseys Wholesale Authentic Jerseys Wholesale Cheap Hockey Jerseys China Wholesale Football Jerseys From China Wholesale NCAA College Jerseys Cheap Jerseys From China Cheap Jerseys China Cheap Jerseys Cheap NHL Jerseys Cheap NFL Jerseys China